Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M503245200 on July 26, 2005

J. Biol. Chem., Vol. 280, Issue 37, 32379-32388, September 16, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
280/37/32379    most recent
M503245200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marwaha, V.
Right arrow Articles by Goukassian, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marwaha, V.
Right arrow Articles by Goukassian, D. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

T-oligo Treatment Decreases Constitutive and UVB-induced COX-2 Levels through p53- and NF{kappa}B-dependent Repression of the COX-2 Promoter*{boxs}

Vaneeta Marwaha{ddagger}1, Ya-Hui Chen{ddagger}12, Elizabeth Helms{ddagger}, Simin Arad{ddagger}, Hiroyasu Inoue§, Evelyn Bord¶, Raj Kishore¶, Raffi Der Sarkissian||, Barbara A. Gilchrest{ddagger}3, and David A. Goukassian{ddagger}4

From the {ddagger}Departments of Dermatology and ||Division of Facial Plastic and Reconstructive Surgery, Boston University School of Medicine, Boston, Massachusetts 02118, §Nara Women's University, Nara 630-8506, Japan and Division of Cardiovascular Research, St. Elizabeth's Medical Center, Boston, Massachusetts 02135

Chronically irradiated murine skin and UV light-induced squamous cell carcinomas overexpress the inducible isoform of cyclooxygenase (COX-2), and COX-2 inhibition reduces photocarcinogenesis in mice. We have reported previously that DNA oligonucleotides substantially homologous to the telomere 3'-overhang (T-oligos) induce DNA repair capacity and multiple other cancer prevention responses, in part through up-regulation and activation of p53. To determine whether T-oligos affect COX-2 expression, human newborn keratinocytes and fibroblasts were pretreated with T-oligos or diluent alone for 24 h, UV-irradiated, and processed for Western blotting. In both cell types, T-oligos transcriptionally down-regulated base-line and UV light-induced COX-2 expression, coincident with p53 activation. In fibroblasts with wild type versus dominant negative p53 (p53WT versus p53DN), T-oligos decreased constitutive expression of a COX-2 reporter plasmid by >50%. We then examined NF{kappa}B, a known positive regulator of COX-2 transcription. In p53WT but not in p53DN fibroblasts and in human keratinocytes, T-oligos decreased readout of an NF{kappa}B promoter-driven reporter plasmid and decreased NF{kappa}B binding to DNA. After T-oligo treatment and subsequent UV irradiation, binding of the transcriptional co-activator protein p300 to NF{kappa}B was decreased, whereas binding of p300 to p53 was increased. Human skin explants provided with T-oligos had markedly decreased COX-2 immunostaining both at base-line and post-UV light, coincident with increased p53 immunostaining. We conclude that T-oligos transcriptionally down-regulate COX-2 expression in human skin via activation and up-regulation of p53, at least in part by inhibiting NF{kappa}B transcriptional activation. Decreased COX-2 expression may contribute to the observed ability of T-oligos to reduce photocarcinogenesis.


Received for publication, March 24, 2005 , and in revised form, July 14, 2005.

* This work was supported in part by National Institutes of Health Grant RO-1 CA105156-01 and by the Herzog Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{boxs} The on-line version of this article (available at http://www.jbc.org) contains Figs. S1–S7.

1 Both authors contributed equally to this work.

2 Supported by the Veterans General Hospital, Kaohsiung, Taiwan. Present address: Dept. of Dermatology, Veterans General Hospital, Kaohsiung, Taiwan.

3 To whom correspondence may be addressed: Dept. of Dermatology, Boston University School of Medicine, 609 Albany St., Boston, MA 02118. Tel.: 617-638-5541; Fax: 617-638-5515; E-mail: bgilchre{at}bu.edu. 4 To whom correspondence may be addressed: Dept. of Dermatology, Boston University School of Medicine, 609 Albany St., Boston, MA 02118, Tel.: 617-638-5541; Fax: 617-638-5515; E-mail: dgoukass{at}bu.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
S. Arad, E. Zattra, J. Hebert, E. H. Epstein Jr., D. A. Goukassian, and B. A. Gilchrest
Topical Thymidine Dinucleotide Treatment Reduces Development of Ultraviolet-Induced Basal Cell Carcinoma in Ptch-1+/- Mice
Am. J. Pathol., May 1, 2008; 172(5): 1248 - 1255.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
H. Aoki, E. Iwado, M. S. Eller, Y. Kondo, K. Fujiwara, G.-Z. Li, K. R. Hess, D. R. Siwak, R. Sawaya, G. B. Mills, et al.
Telomere 3' overhang-specific DNA oligonucleotides induce autophagy in malignant glioma cells
FASEB J, September 1, 2007; 21(11): 2918 - 2930.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Gu, R. P. Singh, S. Dhanalakshmi, C. Agarwal, and R. Agarwal
Silibinin Inhibits Inflammatory and Angiogenic Attributes in Photocarcinogenesis in SKH-1 Hairless Mice
Cancer Res., April 1, 2007; 67(7): 3483 - 3491.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K.-S. Chun, J. K. Akunda, and R. Langenbach
Cyclooxygenase-2 Inhibits UVB-Induced Apoptosis in Mouse Skin by Activating the Prostaglandin E2 Receptors, EP2 and EP4
Cancer Res., March 1, 2007; 67(5): 2015 - 2021.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. Lopez-Knowles, S. Hernandez, M. Kogevinas, J. Lloreta, A. Amoros, A. Tardon, A. Carrato, S. Kishore, C. Serra, N. Malats, et al.
The p53 Pathway and Outcome among Patients with T1G3 Bladder Tumors.
Clin. Cancer Res., October 15, 2006; 12(20): 6029 - 6036.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement